Receiving a rare disease diagnosis often takes five years or more and involves multiple doctors, specialists, and misdiagnoses. Improving the diagnostic process can help shorten this journey for the rare disease community. #RareDisease
AstraZeneca
Pharmaceutical Manufacturing
Cambridge, Cambridgeshire 3,787,117 followers
About us
We're transforming the future of healthcare by unlocking the power of what science can do for people, society and the planet. For more information, visit www.astrazeneca.com. Community Guidelines: bit.ly/2MgAcio
- Website
-
http://www.astrazeneca.com
External link for AstraZeneca
- Industry
- Pharmaceutical Manufacturing
- Company size
- 10,001+ employees
- Headquarters
- Cambridge, Cambridgeshire
- Type
- Public Company
- Specialties
- Pharmaceutical, Biopharmaceutical, Innovation, Research and development, and Global business
Locations
-
Primary
Get directions
1 Francis Crick Avenue
Cambridge Biomedical Campus
Cambridge, Cambridgeshire CB2 0AA, GB
-
Get directions
Astraallen
Sodertalje, Stockholm County 152 57, SE
Employees at AstraZeneca
Updates
-
Final call for youth health leaders! 🌍 Applications close soon for our Young Health Programme Fellowships and Scholarships. Don’t miss your opportunity to join a global community driving positive change for people, society and planet. Apply now ➡️ https://lnkd.in/eKEDziR9 In partnership with One Young World and AFS Youth Assembly. #YoungHealthProgramme
-
-
The FORWD Summit brought together experts from across the healthcare landscape to explore the power of real-world data (RWD) and help build partnerships to help realise it. We discussed how RWD data can drive meaningful improvements across research, care, and policy and to unlock the full potential of RWD and deliver real impact for patients. #FORWDSummit2026
-
Discussions at this year’s congress will drive the rapidly evolving lung cancer treatment landscape forward. As leaders in the field, we continue to follow the science with purpose — driving innovation, strengthening collaborations, and improving outcomes and quality of life for everyone affected by lung cancer. #ELCC26
-
Our Oncology R&D team is harnessing the power of transformational technologies such as data and AI, computational pathology and digital health to better understand complex cancer biology, identify and select patients for treatment and increase the probability of success in the clinic. Explore how transformational technologies are a key part of our Oncology R&D strategy: https://lnkd.in/egprnxAR #Innovation #WhatScienceCanDo
-
Real-world data (RWD) is most powerful when we work together to unlock its full potential across trials, care and policy to improve outcomes for patients.💡 At our inaugural FORWD Summit we were able to do just that, bringing together experts from across the healthcare ecosystem – sharing best practices and building connections. Thank you to every speaker and delegate who contributed to the discussions. We look forward to building on these insights and continuing the conversation. #FORWDSummit2026
-
Multiple myeloma (MM) is a complex blood cancer that affects every patient differently. Despite therapeutic advances, MM remains an incurable disease with almost all patients at high risk for relapse, even after achieving remission. We are committed to supporting people living with MM, their families and the MM community. Through ongoing collaboration and research, we aim to explore new approaches that may help improve care for MM in the future. Click through to learn more. #MyelomaAwarenessMonth
-
Three years after making a joint commitment at COP27, the Sustainable Markets Initiative (SMI) Health Systems Task Force - chaired by our CEO Pascal Soriot - is proving that collaborative action delivers real results in reducing healthcare's environmental footprint. Working alongside global healthcare leaders, we're proud to contribute to tangible progress: ✓ Over 1 million tonnes of CO₂e in potential savings through collective renewable energy procurement in China and India ✓ Supplier climate commitments doubled annually since 2023 ✓ World's first global LCA standard for pharmaceutical products launched to drive transparency and sustainable medicine design Read more: https://lnkd.in/eA49GtCf
-
-
We recently hosted the World Economic Forum’s (WEF) community of Chief Operating and Supply Chain Officers at our manufacturing site in Södertälje, Sweden for an important dialogue on how the evolving landscape is reshaping operating models and supply networks. As a recognised WEF Global Lighthouse, Södertälje is an ideal facility to exemplify how we are harnessing digital innovation and AI to transform the way medicines are developed, made, and supplied. Yet technology is only part of the story – resilience and sustainability require collaboration across industries. Together, we’re shaping a more resilient, future‑ready healthcare ecosystem that will serve people, society and the planet. #WEF #LighthouseNetwork
-
-
Over 4,500 of our scientists have participated in My Green Lab Certification to embed sustainable science within our laboratories. From R&D to our manufacturing supply network, we've reduced our environmental footprint through decreased energy, waste, and water usage, enabling 97 of our labs to achieve Green—the highest level of certification. #WhatScienceCanDo #MyGreenLab
-